Prospective randomized clinical trial on the effects of latanoprost, travoprost and bimatoprost on latanoprost non-responders.

CONCLUSION: There is no added benefit of switching latanoprost to another topical prostaglandin for patients who are initially non-responders. Regression towards the mean and the Hawthorne effect are probably important factors explaining the additional IOP reduction obtained after randomization and explain the result of most switch studies. PMID: 31164290 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31164290?dopt=Abstract

Source: Journal Francais d Ophtalmologie - June 6, 2019 Category: Opthalmology Tags: J Fr Ophtalmol Source Type: research